📊 PRGO Key Takeaways
Is PERRIGO Co plc (PRGO) a Good Investment?
Perrigo faces severe financial distress with operating losses of $372.3M, negative operating cash flow of $113.6M, and unsustainable free cash flow burn despite modest capex. The company cannot service $3.6B in debt from operations and lacks sufficient earnings power to stabilize, creating imminent refinancing and solvency risks absent dramatic operational restructuring.
PERRIGO Co plc Key Strengths (PRGO)
- Adequate gross margin of 33.6% indicates core products retain pricing power
- Strong short-term liquidity with 2.72x current ratio and 1.59x quick ratio
- Cash position of $357.2M provides near-term operational buffer
PRGO Stock Risks: PERRIGO Co plc Investment Risks
- Negative operating cash flow of -$113.6M indicates core business cannot fund operations
- Operating margin deeply negative at -38.4% with deteriorating profitability trajectory
- Unsustainable debt-to-equity of 1.45x combined with negative cash generation creates refinancing risk
- Interest coverage ratio N/A, indicating insufficient operating income to cover debt obligations
- Negative free cash flow of -$127.4M with declining revenue suggests structural operational challenges
Key Metrics to Watch
- Operating cash flow trend and path to positive generation
- Operating margin recovery and net income stabilization
- Revenue trajectory stabilization and underlying margin improvement
- Debt refinancing schedule and covenant compliance
- Cash burn rate and liquidity runway
PERRIGO Co plc (PRGO) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.72x current ratio provides a solid financial cushion.
PRGO Profit Margin, ROE & Profitability Analysis
PRGO vs Healthcare Sector: How PERRIGO Co plc Compares
How PERRIGO Co plc compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is PERRIGO Co plc Stock Overvalued? PRGO Valuation Analysis 2026
Based on fundamental analysis, PERRIGO Co plc shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
PERRIGO Co plc Balance Sheet: PRGO Debt, Cash & Liquidity
PRGO Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: PERRIGO Co plc's revenue has grown significantly by 12% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.09 indicates the company is currently unprofitable.
PRGO Revenue Growth, EPS Growth & YoY Performance
PRGO Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $969.2M | -$6.4M | $-0.05 |
| Q3 2025 | $1.0B | $2.0M | $-0.05 |
| Q2 2025 | $1.1B | $2.0M | $-0.06 |
| Q1 2025 | $1.0B | $2.0M | $0.01 |
| Q3 2024 | $1.1B | $2.0M | $0.10 |
| Q2 2024 | $1.1B | $2.0M | $0.04 |
| Q1 2024 | $1.1B | $2.0M | $0.01 |
| Q3 2023 | $1.1B | -$2.4M | $0.10 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
PERRIGO Co plc Dividends, Buybacks & Capital Allocation
PRGO SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for PERRIGO Co plc (CIK: 0001585364)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| May 15, 2026 | 4 | xslF345X06/wk-form4_1778878789.xml | View → |
| May 15, 2026 | 4 | xslF345X06/wk-form4_1778874091.xml | View → |
| May 15, 2026 | 4 | xslF345X06/wk-form4_1778873926.xml | View → |
| May 15, 2026 | 4 | xslF345X06/wk-form4_1778873820.xml | View → |
| May 15, 2026 | 4 | xslF345X06/wk-form4_1778873718.xml | View → |
❓ Frequently Asked Questions about PRGO
What is the AI rating for PRGO?
PERRIGO Co plc (PRGO) has an AI grade of D with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PRGO's key strengths?
Claude: Adequate gross margin of 33.6% indicates core products retain pricing power. Strong short-term liquidity with 2.72x current ratio and 1.59x quick ratio.
What are the risks of investing in PRGO?
Claude: Negative operating cash flow of -$113.6M indicates core business cannot fund operations. Operating margin deeply negative at -38.4% with deteriorating profitability trajectory.
What is PRGO's revenue and growth?
PERRIGO Co plc reported revenue of $969.2M.
Does PRGO pay dividends?
PERRIGO Co plc pays dividends, with $39.9M distributed to shareholders in the trailing twelve months.
Where can I find PRGO SEC filings?
Official SEC filings for PERRIGO Co plc (CIK: 0001585364) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PRGO's EPS?
PERRIGO Co plc has a diluted EPS of $-2.87.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PRGO's fundamental grade?
Based on our AI fundamental analysis in May 2026, PERRIGO Co plc has a D grade with 88% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PRGO stock overvalued or undervalued?
Valuation metrics for PRGO: ROE of -16.0% (sector avg: 15%), net margin of -41.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PRGO's AI grade for 2026?
Our dual AI analysis gives PERRIGO Co plc a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PRGO's free cash flow?
PERRIGO Co plc's operating cash flow is $-113.6M, with capital expenditures of $13.8M. FCF margin is -13.1%.
How does PRGO compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -41.1% (avg: 12%), ROE -16.0% (avg: 15%), current ratio 2.72 (avg: 2).